APA
ABBV icon

Allegiant Private Advisors’s AbbVie ABBV Stock Holding History

Allegiant Private Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$273K Sell
2,425
-311
-11% -$35K 0.04% 144
2021
Q1 		$296K Buy
+2,736
New +$293K 0.05% 128

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Allegiant Private Advisors's ABBV Position: Q2 2021 in Review

Allegiant Private Advisors reduced its AbbVie (ABBV) stake by 11% in Q2 2021, selling an estimated $35K and leaving 2,425 shares worth $273K. The position accounts for 0.04% of the portfolio, ranked #144.

Allegiant Private Advisors first reported a position in ABBV in Q1 2021 and has held it in 2 quarters since. The position peaked at $296K in Q1 2021. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Allegiant Private Advisors held 2,425 shares of AbbVie worth $273K as of Q2 2021.
  • Allegiant Private Advisors sold 311 AbbVie shares in Q2 2021, an estimated $35K.
  • AbbVie made up 0.04% of Allegiant Private Advisors's portfolio in Q2 2021, its #144 holding.
  • Allegiant Private Advisors first reported a position in AbbVie in Q1 2021 and has held it in 2 quarters since.
  • Allegiant Private Advisors's AbbVie position peaked at $296K in Q1 2021.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.